Abstract 3463: Identification and characterization of novel cancer cell derived factors that dictate vascular endothelial cell biology von Walshe, Tony, Bourdelais, Justin J., Lee, Arleide, Ouro-Djobo, Rakib, Vishnudas, Vivek, Kiebish, Michael, Sarangarajan, Rangaprasad, Narain, Niven R.

Volltext

Abstract 2335: API 31510 - a novel anti-angiogenic modulator of endothelial cells and the tumor microenvironment von Walshe, Tony E., Bourdelais, Justin J., Vishnudas, Vivek, Sarangarajan, Rangaprasad, Narain, Niven R.

Volltext

Abstract 3735: Increased efficacy with use of combination therapy of API 31510 and gemcitabine in the treatment of pancreatic cancer von Narain, Niven R., Sarangarajan, Rangaprasad, Ouro-Djobo, Rakib, Bourdelais, Justin J., Grund, Eric, Vishnudas, Vivek, Mauro, Lucia M., Lens, Assuan, Yunis, Adel, Agarwal, Shuili, Song, Paul Y., McCook, John P., Jimenez, Joaquin J.

Volltext

Abstract 212: BPM 31510 synergizes gemcitabine efficacy in pancreatic adenocarcinoma via mechanism independent of its anti-Warburg influence on metabolism von Dadali, Tulin, Diers, Anne R., Ouro-Djobo, Rakib, Bourdelais, Justin, Benaim, Ezer, Jambhekar, Bianca, Walshe, Tony E., Vishnudas, Vivek K., Jimenez, Joaquin J., Sarangarajan, Rangaprasad, Narain, Niven R.

Volltext

Abstract C117: BPM 31510 enhances efficacy of gemcitabine through orthogonal mechanisms in a preclinical model of pancreatic adenocarcinoma von Dadali, Tulin, Diers, Anne R., Lee, Arleide, Ouro-Djobo, Rakibou, Bourdelais, Justin, Benaim, Ezer, Jambhekar, Bianca, Walshe, Tony E., Jimenez, Joaquin J., Vishnudas, Vivek K., Sarangarajan, Rangaprasad, Narain, Niven R.

Volltext